irinotecan has been researched along with fosbretabulin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cedzik, D; Chen, R; Collette, A; Leisten, J; Liu, W; Lu, L; Man, HW; Muller, GW; Narla, RK; Raymon, HK; Ruchelman, AL; Zhang, L | 1 |
| Guo, K; Li, J; Ma, X; Wu, L; Zhang, C | 1 |
| Ahmed, B; De Boeck, G; de Bruijn, EA; Guetens, G; Landuyt, W; van Oosterom, AT; Wildiers, H | 1 |
1 review(s) available for irinotecan and fosbretabulin
| Article | Year |
|---|---|
Recent advances in combretastatin A-4 codrugs for cancer therapy.
Topics: Antineoplastic Agents, Phytogenic; Drug Design; Humans; Neoplasms; Organophosphates; Stilbenes; Water | 2022 |
2 other study(ies) available for irinotecan and fosbretabulin
| Article | Year |
|---|---|
1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4.
Topics: Alkenes; Animals; Antineoplastic Agents; Benzene Derivatives; Cell Proliferation; Colorectal Neoplasms; Cyclic Nucleotide Phosphodiesterases, Type 4; HCT116 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Molecular Dynamics Simulation; Phosphodiesterase Inhibitors; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2011 |
Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequence.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Division; Drug Interactions; Drug Synergism; Humans; Irinotecan; Neoplasm Transplantation; Rats; Rhabdomyosarcoma; Stilbenes; Time Factors; Tumor Cells, Cultured | 2004 |